Pulse Biosciences Inc
Uždarymo kaina
SektoriusSveikatos priežiūra
24.35 -9.48
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
24.35
Max
25.57
Pajamos | -1.1M -19M |
|---|---|
Pardavimai | 137K 401K |
Pelnas, tenkantis vienai akcijai | -0.241 |
Pelno marža | -4,633.666 |
Darbuotojai | 116 |
EBITDA | -1.4M -19M |
Rekomendacijos | Pirkti |
|---|---|
12 mėnesių prognozė | +27.21% upside |
Kitas uždarbis | 2026-08-11 |
|---|
Rinkos kapitalizacija | 179M 1.7B |
|---|---|
Ankstesnė atidarymo kaina | 33.83 |
Ankstesnė uždarymo kaina | 24.35 |
Naujienos nuotaikos
By Acuity
34%
66%
85 / 342 reitingas Healthcare
Pulse Biosciences Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę Pulse Biosciences Inc
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
